ADENOCARCINOMA OF LUNG
Clinical trials for ADENOCARCINOMA OF LUNG explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF LUNG trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene-Edited cell therapy for lung cancer trial pulled before start
Disease control TerminatedThis trial aimed to test a new treatment for people with metastatic non-small cell lung cancer. It used a patient's own immune cells (TILs) that were edited with CRISPR to remove a gene called CISH, potentially making them better at fighting cancer. The study was withdrawn before…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New hope for advanced cancers: pfizer tests targeted drug combo
Disease control OngoingThis study tests a new drug, PF-07220060, in people with advanced solid tumors (breast, prostate, lung, and others) that have not responded to standard treatments. The drug is given alone or with hormone therapies to see if it is safe and shrinks tumors. About 362 participants wi…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 18, 2026 12:04 UTC